Does RUXOLITINIB Cause Oedema peripheral? 479 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 479 reports of Oedema peripheral have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.7% of all adverse event reports for RUXOLITINIB.
479
Reports of Oedema peripheral with RUXOLITINIB
0.7%
of all RUXOLITINIB reports
88
Deaths
238
Hospitalizations
How Dangerous Is Oedema peripheral From RUXOLITINIB?
Of the 479 reports, 88 (18.4%) resulted in death, 238 (49.7%) required hospitalization, and 14 (2.9%) were considered life-threatening.
Is Oedema peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 479 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Oedema peripheral?
AMBRISENTAN (2,959)
TREPROSTINIL (2,816)
ADALIMUMAB (2,356)
LENALIDOMIDE (2,298)
AMLODIPINE (2,076)
PREDNISONE (2,029)
METHOTREXATE (1,939)
MACITENTAN (1,932)
RITUXIMAB (1,698)
TOCILIZUMAB (1,574)
Which RUXOLITINIB Alternatives Have Lower Oedema peripheral Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE